Public record
Cholecalciferol: the public record
Each table is computed from the named federal dataset as of its data date; the method is under each one.
Adverse event reports
Most reported events in FDA adverse event reports for cholecalciferol
Through 2026-10-28, FDA had received 324,687 adverse event reports for cholecalciferol, 202,829 of them marked serious by the reporter. The symptom terms named most often were fatigue (31,111), diarrhoea (22,814) and nausea (22,688).
| Measure | Value | Note |
|---|---|---|
| All reports received | 324,687 | |
| Reports the reporter marked serious | 202,829 | death, hospitalisation, disability or similar outcome |
| Fatigue | 31,111 reports | |
| Diarrhoea | 22,814 reports | |
| Nausea | 22,688 reports | |
| Headache | 20,849 reports | |
| Pain | 18,559 reports |
How this was calculated
Counted FAERS reports listing this active substance, then the reaction terms named most often. A report can name several reactions, and a term can describe the illness being treated and not an effect of the drug. Terms about product use or complaints rather than symptoms (for example off label use) were left out of the list.
Reports where FDA recorded cholecalciferol as a single-ingredient active substance (any brand), all years to 2026-10-28
FAERS reports are unverified and do not prove the drug caused the event. Reporting rises with use, publicity and lawsuits, so these counts cannot give rates or risks and cannot be compared between drugs.